The VTC Innovation Fund will primarily invest in early-stage life sciences and technology opportunities in, or with a strong connection to, the Commonwealth of Virginia. In conjunction with a broad network of resources across Virginia, the Fund leverages its management team and advisory board’s unique breadth of industry experience and relationships to partner with exceptional management teams to commercialize innovative technologies, accelerate growth, and build long-term value across the Commonwealth.

Investment Amount

Investment Amount

Up to $2m per company (tranched).

Investment Structure

Investment Structure

Syndicated co-investment – equity or convertible debt.

Company Profile

Company Profile

Series A or late seed stage high growth opportunities.

  • Willing to lead roll up of compelling adjacent assets
Geography

Geography

Located in Virginia or outside Virginia with a connection to Virginia Tech or Carilion Clinic.

  • Flexible focus on greater Central and Southwest Virginia
Industry Focus

Industry Focus

  • Life Science – Biopharmaceuticals, pharmaceuticals, medical technology & devices, biotechnology, agriculture & plant science
  • Technology / Special Situational – Disruptive technology, IT or tech-enabled services, advanced manufacturing or agriculture, engineering, advanced materials, advanced chemicals
Company Attributes

Company Attributes

  • Experienced management teams
  • Demonstrated traction and results
  • Large addressable market
  • Innovative tech/intellectual property
  • Tangible exit pathways
  • Potential for rapid growth
  • Executable business model